Publicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (22)

2023

  1. Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results

    Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997

  2. Upadacitinib for moderate to severe atopic dermatitis

    Immunotherapy, Vol. 15, Núm. 11, pp. 799-808

  3. Updated Review on Treatment of Atopic Dermatitis

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 158-167

2022

  1. Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)

    Life

  2. Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: A cohort study

    F1000Research, Vol. 11

  3. Guselkumab as a switching strategy after anti-TNFα, anti-IL17, or anti-IL12/23 therapies in moderate-to-severe psoriasis

    Dermatologic Therapy, Vol. 35, Núm. 10

  4. Guselkumab dosing interval optimization in adult patients with moderate-to-severe psoriasis switching from ustekinumab

    Dermatologic Therapy, Vol. 35, Núm. 11

  5. Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review

    Life, Vol. 12, Núm. 8

  6. Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis

    Life, Vol. 12, Núm. 12

  7. Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series

    International Journal of Dermatology, Vol. 61, Núm. 8, pp. 1029-1033

  8. Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning

    International journal of environmental research and public health, Vol. 19, Núm. 17

2021

  1. Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study

    British Journal of Dermatology

  2. Guselkumab: Mid-term effectiveness, drug survival, and safety in real clinical practice

    Dermatologic Therapy, Vol. 34, Núm. 2

  3. Risankizumab: A pilot study of short-term effectiveness and safety in real clinical practice

    Dermatologic Therapy

  4. Secukinumab: Drug Survival in Clinical Practice Settings

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 4, pp. 361-364

  5. Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: A systematic review and network meta-analysis

    Life, Vol. 11, Núm. 9

2020

  1. A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228

  2. Brodalumab: short-term effectiveness and safety in real clinical practice

    International Journal of Dermatology

  3. Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective study

    International Journal of Dermatology, Vol. 59, Núm. 5, pp. 633-639

  4. Guselkumab: Short-term effectiveness and safety in real clinical practice

    Dermatologic Therapy